Melanie Von Schimmelmann

Melanie Von Schimmelmann has a diverse work experience, primarily in the field of biosciences. Melanie is currently working as the Vice President of Portfolio and Program Management at Solid Biosciences, starting in March 2023. Before that, they held the position of Senior Director of Program Management at AavantiBio, Inc. from November 2020 onwards. Prior to that, they were the Senior Director of Neuroscience at MeiraGTx from March 2019 until October 2020. Melanie also worked at Ovid Therapeutics, where they held the roles of Director from January 2019 until March 2019 and Pre-Clinical Scientist from September 2017 until January 2019. Melanie started their career as a Postdoctoral Fellow at the Icahn School of Medicine at Mount Sinai from February 2012 until August 2017. Before that, they were a Postdoctoral Associate at Rockefeller University from November 2010 until February 2012. Melanie's journey in the industry began with their role as a Pre-doctoral Fellow at NYU Langone Medical Center, where they worked from October 2006 until February 2010.

Melanie Von Schimmelmann completed their Ph.D. in an unspecified field of study at the University of Konstanz - NYU Langone Medical Center in 2010. Prior to that, they attended Carl Laemmle Gymnasium for an unknown duration. Melanie also obtained a Master of Science (M.Sc) degree in Biological Sciences from the University of Konstanz - Columbia University, although no specific start or end years were provided for this achievement.